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Abstract
Background: LuxS may function as a metabolic enzyme or as the synthase of a quorum sensing signalling
molecule, auto-inducer-2 (AI-2); hence, the mechanism underlying phenotypic changes upon luxS inactivation is
not always clear. In Helicobacter pylori, we have recently shown that, rather than functioning in recycling
methionine as in most bacteria, LuxS (along with newly-characterised MccA and MccB), synthesises cysteine via
reverse transsulphuration. In this study, we investigated whether and how LuxS controls motility of H. pylori,
specifically if it has its effects via luxS-required cysteine metabolism or via AI-2 synthesis only.
Results: We report that disruption of luxS renders H. pylori non-motile in soft agar and by microscopy, whereas
disruption of mccAHp or mccBHp (other genes in the cysteine provision pathway) does not, implying that the lost
phenotype is not due to disrupted cysteine provision. The motility defect of the ΔluxSHp mutant was
complemented genetically by luxSHp and also by addition of in vitro synthesised AI-2 or 4, 5-dihydroxy-2,
3-pentanedione (DPD, the precursor of AI-2). In contrast, exogenously added cysteine could not restore motility to
the ΔluxSHp mutant, confirming that AI-2 synthesis, but not the metabolic effect of LuxS was important. Microscopy
showed reduced number and length of flagella in the ΔluxSHp mutant. Immunoblotting identified decreased levels
of FlaA and FlgE but not FlaB in the ΔluxSHp mutant, and RT-PCR showed that the expression of flaA, flgE, motA,
motB, flhA and fliI but not flaB was reduced. Addition of DPD but not cysteine to the ΔluxSHp mutant restored
flagellar gene transcription, and the number and length of flagella.
Conclusions: Our data show that as well as being a metabolic enzyme, H. pylori LuxS has an alternative role in
regulation of motility by modulating flagellar transcripts and flagellar biosynthesis through production of the
signalling molecule AI-2.
Background
Many bacteria release extra-cellular signalling molecules
(auto-inducers) to perform intercellular communication.
It is generally assumed that auto-inducers are employed
to regulate aspects of bacterial behaviour in response to
cell population density (so-called quorum sensing). This
includes changes in the expression of genes crucial for
bacterial survival or virulence [1,2]. Auto-inducer-2
(AI-2) production is widespread among bacterial species;
its formation is catalysed by the enzyme LuxS [3]. Many
Gram-positive and Gram-negative bacterial species pos-
sess LuxS, and in some it has been shown to catalyse
AI-2 production and to control quorum sensing (QS).
Good examples include Vibrio harveyi and Vibrio
cholera, where AI-2 has been shown to regulate density-
dependent bioluminescence and virulence factor produc-
tion, respectively [4,5]. luxS inactivation has also been
shown to cause phenotypic alterations such as biofilm
formation, changes in motility, toxin production, and
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models [3,6].
In addition to its QS role, LuxS catalyses one of the
steps of the activated methyl cycle (AMC). The AMC is
a central metabolic pathway that generates the S-adeno-
sylmethionine (SAM) required by methyltransferases
allowing the widespread methylation of proteins and
DNA needed for cell function. It recycles the toxic pro-
duct of these reactions, S-adenosylhomocysteine (SAH),
to help provide the cell with sulphur-containing amino
acids [7]. As part of the AMC, the Pfs enzyme,
5’-methylthioadenosine nucleosidase/S-adenosylhomo-
cysteine nucleosidase converts SAH to S-ribosylhomo-
cysteine (SRH) which is subsequently converted
to homocysteine by LuxS. The precursor of AI-2, 4, 5-
dihydroxy-2, 3-pentanedione (DPD) is generated as a
by-product of this reaction. Through a process of dehy-
dration and spontaneous cyclisation, some or all of the
DPD is rearranged into a cocktail of chemically related
molecules known as AI-2, including 4-hydroxy-5-
methyl-3 (2H) furanone, (2R, 4S) -2-methyl-2, 3, 3,
4-tetrahydroxy-tetrahydrofuran and furanosyl borate die-
ster. These have been shown to function as signals of
communication between bacteria [3,8,9]. In some organ-
isms, the AMC is different. For example, in Pseudomo-
nas aeruginosa, LuxS and Pfs are replaced by a single
enzyme (SAH hydrolase) which converts SAH to homo-
cysteine in a one step reaction without the concomitant
production of DPD [7].
Helicobacter pylori, a Gram-negative bacterium which
causes peptic ulceration, gastric cancer and gastric
mucosa-associated lymphoid tissue (MALT) lymphoma,
contains a luxS homologue and produces AI-2 [10-12].
luxSHp (HP010526695; JHP0097J99)i sp o s i t i o n e dn e x tt o
housekeeping genes mccAHp (HP010726695; JHP0099J99)
and mccBHp (HP010626695;J H P 0 0 9 8 J99)o nt h eH. pylori
chromosome, in a putative operon [13-15]. Data from
our laboratory have demonstrated that the AMC of
H. pylori is incomplete, and that LuxSHp,M c c A Hp and
MccBHp constitute the sole cysteine biosynthetic path-
way in this bacterium via a reverse transsulphuration
pathway (RTSP) [15].
To date, the mechanisms underlying phenotypic changes
exhibited as a result of luxSHp inactivation remain elusive.
Two ΔluxSHp mutants have been shown to form biofilms
more efficiently than the parent strain, indicating a possi-
ble but counterintuitive role of luxSHp in biofilm reduction
[16]. A subsequent study demonstrated that ΔluxSHp
mutants in two strains lost growth-phase-dependent regu-
lation of the gene encoding the major flagellin FlaA, and
that cell culture supernatant containing AI-2 could
increase flaA transcription [17]. Studies by two indepen-
dent groups looked at fitness of ΔluxSHp mutants in vivo
using mouse and gerbil models, respectively [18,19]. The
motility of ΔluxSHp mutants was diminished and bacterial
fitness reduced in co-infection experiments. Restoration of
luxSHp by genetic complementation partially restored
these phenotypes [18,19]. The authors argued that the
decreased fitness in the ΔluxSHp mutant was most likely
due to the disruption of the cycle of SRH consumption
and homocysteine synthesis and that AI-2 seemed unlikely
to be a QS signal molecule [18]. More recently however,
Rader et al. reported that luxSHp disruption affected flagel-
lar morphology in the absence of one of the transcriptional
regulators (s
28, flgS or flgM), and that this could be com-
plemented upon the addition of DPD. They reported that
loss of luxSHp caused decreased transcription of the flagel-
lar regulator flhA, and that expression of flhA was induced
by DPD [20]. This complementation through the addition
of exogenous DPD resurrected the possibility of LuxS-
dependent signalling in H. pylori.
There are several possible mechanisms whereby a
motility defect could be associated with loss of luxSHp.
Firstly, reduced flagellar structural gene transcription
and related protein synthesis would lead to loss of fla-
gella. Secondly, normal flagella structures may be
synthesised in the ΔluxS mutant but lack of a functional
motor may prevent rotation. Thirdly, both motor and
flagellum may be functional, but unable to respond to
tactic signals, leading to aimless movement.
In this study, we set out to distinguish between the
mechanisms underlying the alteration in motility of
ΔluxSHp mutants, and to clarify whether this originated
from a disruption of metabolism or QS. To do this,
electron microscopy was employed to examine flagellar
assembly and the levels of individual components of fla-
gella were assessed at a transcriptional and translational
level. Our demonstration here of the lack of motility
defects in mutants disrupted in components of the
RTSP other than LuxS, coupled to the inability of
cysteine to complement the motility defect of the
ΔluxSHp mutant, shows that disruption of cysteine bio-
synthesis is not the mechanism underlying the reduction
in motility. In contrast, we show that exogenously added
AI-2 (or DPD) influences motility via regulating flagellar
gene transcription (and thus the number and length of
flagella). This supports the existence of an additional
role for LuxS in H. pylori as a signalling molecule
synthase.
Methods
Strains and growth culture conditions
All strains used in this study are listed in Table 1. DH5a
was used in the production of proteins needed for AI-2
biosynthesis and cloning [21]. V. harveyi BB170 was
used in the bioluminescence bioassay as a reporter
strain [22]. E. coli strains were routinely grown in Luria-
Bertani (LB) (Bacto) broth or on agar plates at 37°C.
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Page 2 of 15V. harveyi was grown in LB or AB medium [23] at 30°C,
also under normal atmospheric conditions. H. pylori
strains were routinely grown and maintained on Colum-
bia blood agar plates (No.2, with 5% [v/v] horse blood;
Oxoid) or grown in Brucella broth (BB) (Bacto) contain-
ing 7% (v/v) fetal bovine serum (Gibco). H. pylori J99
was incubated at 37 °C for 24 h to 72 h as required in a
MG500 VAIN-cabinet (Don Whitley Scientific) in an
atmosphere of 5% CO2, 86% N2,a n d6 %O 2 (all v/v).
For motility experiments the method of Wand et al.
[24] was used to achieve motile cultures for analysis, see
below. Antibiotics were used at the following concentra-
tions: ampicillin at 100 μg/ml, kanamycin at 30 μg/ml.
Molecular biology methods
Preparation of plasmid DNA, DNA ligation, gel electro-
phoresis and transformation of E. coli strains were per-
formed in accordance with standard methods [25]. All
PCRs were performed with Taq DNA polymerase
(Roche Diagnostics, Lewes, UK). TA cloning was carried
out using the pGEM-T vector system (Promega, Madi-
son, WI). Plasmid DNA was extracted using the
QIAquick spin miniprep kit (QIAGEN, UK). DNA frag-
ments were purified from agarose gel using a QIAquick
gel extraction kit (QIAquick, UK) according to the man-
ufacturer’s instruction. H. pylori genomic DNA was iso-
lated as described previously [26]. DNA sequencing was
conducted using standard fluorescent dye terminator
chemistries, and analysis performed using the Applied
Biosystems 3730 DNA Analyzer system (Geneservice,
Cambridge, UK, Applied Biosystems Inc, Foster City,
CA.). Results were analysed using the Bioedit software
suite [27].
Construction of the complemented ΔluxS
+ strain
H. pylori J99 wild-type was transformed with the plasmid
pGEMTluxSXN396 containing a km-sacB construct
encoding kanamycin resistance (Km
r)a n d( 5 % )s u c r o s e
sensitivity (Suc
s) [17]. Disruption of the chromosomal luxS
gene was accomplished by natural transformation, allelic
exchange, and screening for kanamycin-resistance as pre-
viously described [15], resulting in the J99 ΔluxS mutant
strain. The presence of the km-sacB cassette was verified
by amplifying fragments of H. pylori chromosomal DNA
Table 1 Strains and plasmids used in this study
Strains/Plasmids Description Reference
Strains
Vibrio harveyi
BB170 luxN :: Tn5 AI-1 sensor negative; AI-2 sensor positive [43]
Escherichia coli
DH5a endA1 recA1 gyrA96 thi-1 hsdR17(rk
- mk
+) relA1 supE44Δ(lacZYA-argF) U169 F
- F80dlacZΔM15 deoA phoA l
- [21]
DH5a LuxS DH5a containing the plasmid pProEx-luxSEC [8]
DH5a Pfs DH5a containing the plasmid pProEx HT mtan [8]
Helicobacter pylori
J99 (ATCC700824) Wild-type motile strain [44]
J99 ΔluxS J99 derivative; ΔluxS :: km;K m
r [15]
J99ΔluxS-F J99 derivative; ΔluxS :: km-sacB;K m
r Suc
s This study
J99 ΔluxS
+ J99ΔluxS-F derivative; ΔluxS :: km-sacB replaced with original luxS locus; Suc
r Km
s This study
J99 ΔmccA J99 derivative; ΔmccA :: km;K m
r [15]
J99 ΔmccB J99 derivative; ΔmccB :: km;K m
r [15]
J99 ΔflhB J99 derivative; ΔHP0770 Lys
13 to Glu
347;K m
r; non-motile [24]
CCUG 17874* Wild-type strain [29]
17874 ΔflaA 17874 derivative; ΔflaA :: cat;C m
r Paul O’Toole
17874 ΔflgE 17874 derivative; ΔflgE :: km;K m
r [30]
Plasmids
pGEMT Commercial TA cloning vector; Amp
r Promega
pGEMTluxSXN396 pGEM-T with inserted 26695 luxS; ΔluxS :: km-sacB; Suc
s Km
r [17]
pGEMTluxS pGEM-T with inserted full-length luxS fragment This study
pProEx-luxSEC pProEX HT containing the luxS gene of E. coli MG1655 [8]
pProEx HT mtan PProEX HT containing the pfs gene of E. coli [8]
* CCUG 17874 is identical to the type strain NCTC 11637, isolated by B. J. Marshall at Royal Perth Hospital, May 1982 [29].
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Page 3 of 15using primers luxS-F/luxS-R (forward, 5’>GTG GCT TTA
GCG GGA TGT TTT<3’;r e v e r s e ,5 ’>GCGA ACA AAT
CCC CGC TG<3’)a n dD N As e q u e n c i n g .T h eJ 9 9ΔluxS
was then transformed with plasmid pGEMTluxS (encod-
ing wild-type luxS), and transformants in which km-sacB
had been replaced with the introduced original luxS locus
were selected for sucrose resistance on medium containing
5% sucrose and screened for kanamycin sensitivity. The
presence of the original luxS gene was verified by amplify-
ing fragments on H. pylori chromosomal DNA using pri-
mers luxS-F/luxS-R and DNA sequencing.
Bacterial growth curves and V. harveyi bioluminescence
assay
Bacterial broth cultures were started from a blood agar
plate culture, diluted to an OD600 nm of 0.05 in fresh BB
m e d i u m ,a n dg r o w na t3 7 ° Ci naV A I N - c a b i n e tw i t h
shaking. OD600 nm measurements were taken at the 6 h,
24 h, 48 h and 72 h time points, and at the same time
cell suspensions were harvested and filtered through a
0.2 μmp o r es i z ef i l t e r .T h eA I - 2a c t i v i t yi nc e l lf r e e
supernatants (CFS) was tested as previously described
using the V. harveyi reporter strain BB170 [9,22]. Briefly,
an overnight V. harveyi culture was diluted 1:2500 in
fresh AB medium [23]. CFS samples were diluted 1:10
in the AB medium containing BB170 into the 96 well
bioluminescence plates to give a final volume of 200 μl
and were incubated at 30°C. The bioluminescence and
optical density were determined at 30 min intervals for
at least 8 h using a luminometer (Anthos Labtech
LUCY 1.0). AI-2 activity alterations in bioluminescence
were expressed as induction (n-fold) over the negative
control.
Motility assay
Plate motility assay of H. pylori was performed in Bru-
cella broth medium (BD Biosciences), supplemented
with 7% (v/v) fetal bovine serum (Gibco), 0.35%-0.45%
(w/v) agar (No.1, Oxoid) and the indicator, 40 μg/ml tri-
phenyl tetrazolium chloride (Sigma, UK). Inclusion of
this indicator made it easier to see the small recombi-
nant colonies. Plates were seeded with 5 μl H. pylori
liquid culture (forming a circle with 3 mm diameter)
standardised to an OD600 nm of 1.0 and were incubated
at 37°C for up to 7 days under the conditions described
above. The motility halos were recorded using a digital
camera and the area of each halo was measured using a
GS-800 Calibrated Densitometer (Biorad).
Motility analysis was also carried out by direct obser-
vation under phase-contrast microscopy using a Nikon
Eclipse E600 after cells were grown in co-culture condi-
tions as used by Wand et al. [24]. Briefly, co-cultures of
H. pylori-human gastric adenocarcinoma (AGS) cells
were prepared (described below). After 24 h, 10 μl
culture was placed onto a microscope slide and covered
with a coverslip and freely-motile H. pylori cells were
analysed under the microscope.
Plate motility bioassay using chemically defined
media (CDM)
The liquid chemically defined media were prepared as
previously described [15,28]. 60 ml of sterile chemically
defined media were added to 40 ml of molten 1% Oxoid
No. 1 agar base to make 0.4% semi-solid chemically
defined agar. Cysteine supplemented plates (CSP) were
made by adding cysteine to the molten agar, shortly
before it set. The final concentration of cysteine was
1.0 mM, which was non-limiting for H. pylori growth.
The centre of each plate was seeded with one-day incu-
bated H. pylori cells and was incubated for 5 days under
the conditions described above. The motility halos were
recorded using a digital camera and the area of each
halo was measured using a GS-800 Calibrated Densit-
ometer (Biorad).
Motility assay with AI-2 complementation
AI-2 was synthesised enzymatically as described pre-
viously using purified proteins LuxSE. coli and PfsE. coli
[8]. For complementation of the ΔluxSHp motility phe-
notype, soft motility agar plates (0.4% w/v) were made
as previously described. Bioluminescence activity of the
AI-2 product was quantified using the V. harveyi bioas-
say and compared to CFS from H. pylori wild-type
broth culture standardised to an OD600 nm of 1.0 at the
time point in the growth curve that maximal AI-2 activ-
ity was measured. 1/400 diluted in vitro synthesised
AI-2 product shows the same level of bioluminescence
as seen in the H. pylori wild-type CFS in the V. harveyi
bioassay. Therefore, in the complementation experiment
AI-2 was added to motility plates to a final concentra-
tion of 0.25% (v/v). 24 h H. pylori cultures were seeded
individually onto the centre of each motility plate and
incubated for 5 days. The area of outward migration
was recorded with a digital camera and measured using
a GS-800 Calibrated Densitometer (Biorad).
Tissue culture and bacterial co-culture
All chemicals were obtained from Gibco, UK. AGS cells
were grown in nutrient mixture Ham’s F-12 supplemen-
ted with L-glutamine (200 mM) and fetal bovine serum
(Gibco) (10% v/v) in a 37°C incubator containing 5%
CO2. After cells had grown to confluency, a 1 in 5 or 1
in 8 dilution was added to a 75 cm
2 flask containing
fresh media mix and incubated in the same conditions
as before to allow cells to re-grow to confluency.
AGS cells were counted using the trypan (0.35% v/v)
blue dye method. Cells were seeded at a density of 1 × 10
5
cells/ml into 6 well plates and grown to 80% confluency.
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fresh F-12 media. Plates were inoculated with 24 h
H. pylori liquid cultures standardised to an OD600 nm of
0.1 and incubated for one day in a microaerobic environ-
ment. Bacterial cells were then analysed using a phase-
contrast Nikon Eclipse E600 microscope and electron
microscopy.
Electron microscopy (EM)
H. pylori cells were pre-grown as described above for
motility analysis. 15 μl of culture was allowed to settle
on a carbon formvar grid (Agar Scientific) for 1 min.
The suspension was removed and the grid washed by
addition of 15 μl of Phosphate Buffered Saline (PBS) for
an additional minute. This was removed and the cells
stained with 0.5% Phospho-tungstic acid (PTA) pH 7.0
for 1 min. Grids were examined and pictures taken
using a JEOL JEM1010 Transmission Electron Micro-
scope. We quantified changes, rounding to the nearest
5% and quote means ± SD. Essentially, three groups of
H. pylori cell samples prepared on different dates were
examined. Each group of samples contained wild-type,
ΔluxS and ΔluxS
+ cells treated and not treated with
DPD. For each group, 100 H. pylori cells from each cul-
ture sample were examined.
Cysteine and DPD complementation experiments
Cysteine from Sigma products was dissolved in distilled
water according to the manufacturer’s recommendation.
Synthetic DPD was purchased from Omm Scientific Inc.
DPD (AI-2) activity was quantified with the biolumines-
cence bioassay and compared to wild-type H. pylori
grown to an OD600 nm of 1.0, at which maximal AI-2
activity was obtained. To test for complementation of
motility, DPD (at a physiological concentration of 150
μM) and non-limiting cysteine (1.0 mM) were added
individually to bacteria-AGS cell co-cultures. DPD was
added after 10 h of incubation and once again after 18 h
of incubation. Cysteine was added from the beginning of
incubation. Bacterial motility and cells were observed
and visualized by phase-contrast microscope and EM,
respectively. For gene transcription studies, DPD
(150 μM) and cysteine (1.0 mM) were also added (in the
same way) individually to H. pylori liquid cultures of dif-
ferent genotypes. After 24 h, RNA was extracted and the
transcript levels of genes of interest were measured.
Protein electrophoresis and western blotting
H. pylori wild-type, its ΔluxSHp mutant, the complemen-
ted ΔluxSHp
+ mutant and controls (H. pylori wild-type
17874 [29], and derived mutants ΔflaA (a kind gift from
Paul O’Toole) and ΔflgE [30]) were grown in Brucella
broth at 37°C for up to 24 h, at which point high levels
of AI-2 activity were detected. To exclude global
differences in protein production between strains, we
corrected our loading for numbers of bacteria rather
than for total protein levels. To do this, 24 h liquid
(Brucella broth) culture of each strain was adjusted to
OD600 nm of 1.0. A 500 μl cell sample of each strain was
then centrifuged at 5500 rpm for 1 min. Culture super-
natants were removed and cell pellets were fully resus-
pended in 1 ml sterile PBS. 100 μl protein sample was
collected. The same volume of 2 × sample buffer was
added and boiled for 10 min. SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) and subsequent immuno-
blotting were carried out as described previously under
standard conditions [25]. The gel contained 10% acryla-
mide. 4 μl protein stock from each strain sample was
loaded into each well of the SDS-PAGE gel. For immu-
noblotting, proteins were transferred from SDS-PAGE
gels to nitrocellulose paper by the methanol Tris-glycine
system described by Towbin et al. [31]. To see whether
similar amounts of protein were loaded using our meth-
odology, membranes were inspected following Ponceau
red staining prior to immunoblotting; protein levels
appeared similar on each membrane by inspection. The
blots were incubated with rabbit polyclonal antibodies
against H. pylori flagellin and hook protein (a generous
gift from Paul O’Toole) [32]. Bound antibodies were
detected using secondary anti-rabbit IgG alkaline phos-
phatase conjugate antibody (Sigma, UK). The blots were
developed using the BCIP/NBT substrate system (Dako,
UK). The quantitative scan of the protein bands was
performed using a GS-800 Calibrated Densitometer
(Biorad). The reflective density (RD) of each protein
band was measured using the Quantity One 4.6.5 soft-
ware (Biorad).
RNA extraction and transcription analysis
RNA was isolated from H. pylori cells grown in BB
medium for 24 h. Cultures were treated with RNA pro-
tection reagent (QIAGEN, UK) and RNA was extracted
using RNeasy mini kit (QIAGEN, UK). Contaminating
g e n o m i cD N Aw a sr e m o v e du s i n gaD N Af r e ek i t
(Ambion). Synthesis of cDNA was performed using
Ominiscript RT kit (QIAGEN, UK) and random hexam-
ers (Roche, Germany). Quantitation of transcripts of
selected genes of interest was accomplished by quantita-
tive reverse transcription-PCRs (qRT-PCRs) using
Rotor-gene 3000. Primers utilised in RT-PCRs are listed
in Table 2. All RT-PCR reaction mixtures contained
12.5 μlo fS Y B RG r e e nM i x( Q I A G E N ,U K ) ,5μlo f
gene specific primers, 2 μl cDNA template (cDNA was
diluted 10-fold prior to adding into the RT-PCR reac-
tions) and RNase free water to a final volume of 25 μl.
The amplification program was 95°C for 15 min,
followed by 35 cycles of 95°C for 15 sec, 56°C for
60 sec, and 72°C for 30 sec. All samples, including the
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plicate. Transcript levels of each gene were normalised
to the 16 S rRNA in each sample. The relative quantity
of transcription of each gene was obtained using Pfaffl’s
analytical methodology.
Statistics
Statistical analysis was by Student’s t test.
Results
The H. pylori ΔluxS mutant lost the ability to produce
AI-2 while the wild-type, ΔmccAHp and ΔmccBHp mutants
did not
O u rp r e v i o u ss t u d yh a sd e m o n s t r a t e dt h a tluxSHp,
mccAHp and mccBHp genes comprise a reverse transul-
phuration pathway in H. pylori,w h i c hi st h es o l e
cysteine biosynthesis pathway [15]. We then wanted to
determine whether these mutants in a motile strain of
H. pylori, J99, would be useful in differentiating whether
H. pylori motility was affected by luxS associated AI-2
production or by cysteine provision. Firstly, we needed
to establish whether mutations in mccHp genes in our
candidate motile strain J99 changed expression of
luxSHp and AI-2 biosynthesis. To do this, H. pylori J99
wild-type and derived ΔmccAHp, ΔmccBHp,a n dΔluxSHp
mutants were grown in Brucella broth containing serum
(10% v/v). Once they reached logarithmic growth phase,
AI-2 activity in the culture supernatant was measured
using the V. harveyi AI-2 bioassay previously described
[4,8]. As expected, the wild-type produced AI-2 in a
growth dependent manner, with AI-2 accumulating dur-
ing the late logarithmic phase, and reaching maximal
levels in the stationary phase. During stationary phase,
AI-2 levels decreased and were almost undetectable by
72 h. Similar data were obtained with ΔmccAHp and
ΔmccBHp mutants, despite the fact that the ΔmccBHp
mutant grew slightly less well than the other mutants
and the wild-type. The ΔluxSHp mutant, unlike the wild-
type and the other two mutants, yielded almost unde-
tectable levels of bioluminescence at each time point,
indicating that the production of AI-2 is luxSHp-depen-
dent and that insertion of a kanamycin cassette (aphA3)
into mccAHp and mccBHp did not affect expression of
the downstream gene luxSHp (Figure. 1A).
Deletion of luxSHp abolishes motility while the ΔmccAHp
and ΔmccBHp mutants remained motile
To investigate whether motility of H. pylori was affected
by cysteine biosynthesis, we first compared the motility
of H. pylori wild-type with ΔluxSHp, ΔmccAHp and
ΔmccBHp mutants. To do this, a 24 h liquid culture of
each strain was spotted onto each quarter of a semi-
solid agar plate and incubated for up to 7 days. The
resulting motility halo areas were quantified after 3, 5
and 7 days of incubation. Halo areas that surrounded
the wild-type, ΔmccAHp and ΔmccBHp strains kept
increasing during continuous incubation, although the
ΔmccAHp strain was slightly delayed in comparison to
the others. After 7 days of culture, the ΔluxSHp mutant
remained almost non-motile and produced a signifi-
cantly (p < 0.001) reduced motility halo compared to
wild-type, ΔmccAHp and ΔmccBHp strains in 3 indepen-
dent repeat experiments (Figure. 1B). After 7 days, the
wild-type, ΔmccAHp and ΔmccBHp mutants produced
h a l o so f( m e a n±S D )8 . 5±0 . 6m m ,n =4 ;5 . 6±0 . 9
mm, n = 4; and 7.8 ± 0.6 mm, n =4i n c r e a s e si nd i a -
meter, respectively, all significantly greater than the
ΔluxSHp mutant which produced a halo size of 1.1 ± 0.1
mm, n = 4. These results revealed that the reduction in
motility was likely a result peculiar to luxSHp mutation
rather than due to disruption of cysteine biosynthesis.
Genetic complementation or exogenous AI-2 can restore
the motility defect of the ΔluxSHp mutant, but exogenous
cysteine addition cannot
To rule out the possibility that second site mutations in
the ΔluxSHp mutant were inhibiting motility, genetic
complementation was performed to create the ΔluxSHp
+
strain (see Materials and Methods). The non-motile
ΔflhB mutant was used as a negative control [24]. 24 h
cultures of wild-type, ΔluxSHp, ΔluxSHp
+ and ΔflhBHp
strains grown in Brucella broth were individually spotted
onto normal motility plates. After 5 days of incubation,
the mean halo diameter of the ΔluxSHp
+ strain was
6.9 ± 0.2 mm, n = 4, which was slightly larger than that
of the wild-type (4.7 ± 0.7 mm, n =4 ) .T h eΔluxSHp
Table 2 Primers utilised in quantitative RT-PCR
Primers Sequence (5’-3’)
16S_F CGA TGA AGC TTC TAG CTT GC
16S_R ATA GGA CAT AGG CTG ATC TC
flaAF CAG GTT CGT ATC GCT ACA GGC
flaAR ATC ACT TCT GCT AAC ACG CCG
flaBF ACT GGG ATT GGG GCG TTA
flaBR TCA ACC TCC CGTCAG CGT C
flgEF GCT CAG GCA CGA TCA CTC TAA
flgER AAC GCC ATG AAA GGT CTT AAT AC
flhAF TCA TTG GAG GGT TTT TAG TGG
flhAR GGT GCG AGT GGC GAC AAT
motAF TGA GTT TAG AGG GGC GAG TG
motAR CCA GTA ATG AGC GGC ACC
motBF TTC AGG GAA AGA AGA AGA GCA A
motBR TCA AAC AGC AAA CTA GAG AAA A
fliIF ACG AGC GAT GAT AGC CCT TTA
fliIR ACC GAT TTC TCT TTG AGC CAT
ureAF GAT GAT GTG ATG GAT GGT GTG G
ureAR TAA GAA CAA CTC ACC AGG AAC C
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(Figure. 2A).
To examine whether AI-2 can influence the motility of
H. pylori, we assessed the motility of the wild-type,
ΔluxSHp and ΔflhB mutants on AI-2 supplemented
plates (ASP). The ASP was prepared using 0.4% soft
agar containing in vitro synthesised AI-2 (0.25% v/v).
The buffer control plate (BCP) was also produced using
0.4% soft agar into which was added the buffer control
solution (0.25% v/v) produced in parallel to in vitro AI-2
synthesis (buffer containing no AI-2). After 5 days of
incubation, the halo size of the wild-type on ASP
increased by 11.2 ± 0.7 mm, n =4 ,c o m p a r e dw i t ha
5.4 ± 0.2 mm, n = 4 increase on the non-supplemented
Figure 1 The ΔluxSHp mutant of H. pylori strain J99 lacks AI-2 and is non-motile unlike other mutants deficient in cysteine
biosynthesis. (A) AI-2 production in J99 wild-type (black column), ΔluxSHp (red column), ΔmccBHp (blue column) and ΔmccAHp (white column)
mutants was measured. Strains were grown in Brucella broth, and aliquots were removed at 24 h, 30 h, 48 h and 72 h to assess the optical
density (wild-type, square; ΔluxSHp, diamond; ΔmccBHp, circle; ΔmccAHp, triangle) and the amount of AI-2 in the filtered culture supernatant using
the V. harveyi bioassay. AI-2 activity is shown as a relative bioluminescence (corrected by OD600nm of H. pylori) in the presence of H. pylori culture
supernatants over the negative control (Brucella broth alone). A diluted in vitro synthesised AI-2 sample was utilised as a qualitative positive
control [8]. Bioluminescence induced by wild-type, ΔmccBHp, and ΔmccAHp strains was significantly greater than that induced by the ΔluxSHp
mutant, as determined by paired Student’s t-test (p < 0.001). The lines represent the growth (OD, righthand axis) and the bars represent the AI-2
activity (bioluminescence, lefthand axis). (B) 5 μl of liquid culture (24 h) of the wild-type, ΔluxSHp, ΔmccBHp and ΔmccAHp mutants was seeded on
each quarter of a soft agar plate. After 3, 5 and 7 days of incubation, the motility halo of each strain was recorded using a digital camera. All
experiments were done in triplicate: a representative experiment is shown and the mean results are presented in the text.
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2B with the left panel of Figure. 2B). Whilst the ΔluxSHp
mutant was non-motile on the BCP, the halo increased
by 4.6 ± 0.4 mm, n = 4 on ASP (Figure 2B). The control
strain ΔflhBHp mutant remained non-motile on the ASP
(Figure. 2B).
Having established an influence on motility for one of
the chemicals reliant on LuxSHp function (AI-2), we
sought to establish whether another (cysteine) would
have a similar influence. Our previous studies revealed
that exogenous cysteine rescues growth defects of
mutants unable to complete cysteine biosynthesis via
the RTSP of H. pylori (ΔluxSHp, ΔmccAHp and ΔmccBHp
mutants) in chemically defined broth [15]. Chemical
complementation of motility was thus performed using
chemically defined plates supplemented with 1.0 mM
cysteine. Methionine was added to these plates as the
sulphur source since all known H. pylori strains are
methionine auxotrophs. After 5 days of incubation,
wild-type H. pylori and ΔmccAHp and ΔmccBHp mutants
formed motility halos of 4.9 ± 0.3 mm, n =4 ;3 . 6±
0.6 mm, n = 4; and 4.3 ± 0.9 mm, n = 4 increases in
diameter, respectively. The ΔluxSHp mutant remained
non-motile (Figure. 2C).
Taken together, these data indicate that the motility
defect of the ΔluxSHp mutant was restored either
Figure 2 AI-2, but not cysteine rescues the motility defect of the ΔLuxSHp mutant.( A )W i l d - t y p e ,ΔluxSHp,a n dΔluxSHp
+ bacteria were
seeded onto soft plates composed of normal medium. The non-motile ΔflhB mutant served as the negative control. (B) Wild-type, ΔluxSHp and
ΔflhBHp bacteria were seeded onto motility plates supplemented with in vitro synthesised AI-2. Wild-type and ΔluxSHp were also seeded on
motility plates containing buffer control solution used for in vitro AI-2 synthesis. (C) Wild-type, ΔluxSHp ΔmccAHp and ΔmccBHp strains were
seeded onto chemically defined motility plates supplemented with cysteine. After 5 days of incubation, the motility halo of each strain on each
plate was recorded using a digital camera and the area of each halo was measured using a GS-800 Calibrated Densitometer (Biorad).
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genous cysteine. This suggests that luxS and AI-2 play a
role in enhancing bacterial motility, rather than an
intact cysteine biosynthesis pathway, implying a likely
role of luxSHp in signalling.
ΔLuxSHp mutants have altered flagella morphology
and motility patterns
Motility plates effectively indicate motility phenotypes of
the population, but do not give any indication of the
structure of the motility organelles (flagella), or the
motility pattern of individual cells. To characterise
the phenotypes underlying the decreased ability of the
ΔluxSHp mutant to swarm in soft agar, we examined
motility of individual bacterial cells using phase-contrast
microscopy and also the flagellar morphology of the
cells using electron microscopy. Cells tested included
wild-type, ΔluxSHp and ΔluxSHp
+,a l lg r o w ni nt h ep r e -
sence and absence of DPD and cysteine. All cells were
grown in co-culture with human gastric adenocarcinoma
(AGS) cells for 24 h before testing, as previous experi-
m e n t si no u rl a b o r a t o r yh a v es h o w nt h a tt h i sg i v e s
highly reproducible results in H. pylori motility
experiments.
Phase-contrast microscopy revealed that > 40% of
wild-type and ΔluxSHp
+ cells were motile; whereas less
than 2% of ΔluxSHp cells were motile. When grown
with exogenous DPD, motile cells again made up > 40%
of the population for wild-type and ΔluxSHp
+ cells, but
now also made up > 40% of the population for ΔluxSHp
cells. Cultures of the ΔluxSHp grown with exogenous
cysteine consistently contained less than 2% motile cells.
To exclude the possibility that the restoration of motility
of ΔluxSHp cells was due to an effect of DPD on AGS
cells rather than on H. pylori,w es e tu pac o n t r o ls a m -
ple in which the wild-type and ΔluxSHp mutant were
co-cultured individually with AGS cells that had been
treated with DPD overnight. DPD was washed off with
the media before co-culturing. As expected, both wild-
type and ΔluxSHp cells in these control cultures showed
very similar motility phenotypes to those co-cultured
with normal AGS cells, indicating that DPD is a func-
tional signalling molecule to H. pylori cells rather than
it working through affecting eukaryotic cells. Moreover,
the approximate speed of motile ΔluxSHp cells was visi-
bly lower compared to the wild-type, ΔluxS
+ and all cell
samples plus DPD.
Electron microscopic images (Figure. 3) showed that
all samples tested (wild-type, ΔluxSHp and ΔluxSHp
+,
grown in the presence or absence of DPD) produced a
flagellar filament of some kind in the majority of bacter-
ial cells, but those of the ΔluxSHp strain were consis-
tently short and usually fewer in number. In our
experiments, nearly all of the wild-type cells tested had
flagella (95% ± 3%, n = 3) and most of these had multi-
ple flagella, which were usually at one pole and typically
3-4 in number (90% ± 3%, n = 3) (Figure. 3A). In con-
trast, fewer ΔluxSHp cells tested had flagella (70% ± 5%,
n = 3) and these were typically shorter and also fewer in
number (30% ± 5%, n = 3 of cells had only one or two
short flagella (Figure. 3B)). The complemented ΔluxSHp
+
cells were similar to wild-type, with nearly all cells pos-
sessing 3-4 normal long flagella at least one pole (95% ±
3 % ,n=3 )( F i g u r e .3 C ) .A d d i t i o no fD P Dt oΔluxSHp
cells also converted them to a wild-type morphology,
with the vast majority producing 3-4 wild-type length
flagella usually present at a single pole (95% ± 3%,
n = 3) (Figure. 3E). Addition of DPD to wild-type cells
had little significant effect with nearly all remaining fla-
gellate as before (95% ± 3%, n = 3) although more cells
were seen with a flagellum at both poles (Figure. 3D).
Addition of DPD to the ΔluxSHp
+ cells had a similar
effect, with more cells with flagella at both poles
(Figure. 3F).
Mutation of luxSHp resulted in the decreased production
of flagellar proteins FlaA and FlgE
The reduced number and length of flagella in ΔluxSHp
cells observed by electron microscopy could emanate
from a number of different changes in the proteome. As
previous work had suggested possible involvement of
major flagella proteins, we investigated these first by
immunoblotting whole cell lysates. Cell lysates were
adjusted so that protein from equivalent numbers of
bacteria was loaded (see Materials and Methods), and
probed with anti-flagellin (FlaA and FlaB) and anti-FlgE
(hook protein) antiserum (Figure. 4). In practice, FlaB
levels were very similar between all wild-type and
mutant strains and were not shown to vary in our sub-
sequent transcription analysis. Our main aim here was
to compare ratios of flagella proteins between wild-types
and mutants, so we expressed results of other flagella
proteins (FlaA and FlgE) relative to FlaB levels within
each strain. H. pylori wild-type 17874, and derived
mutants (ΔflaA and ΔflgE) were used as positive and
negative controls, respectively. In our experiments, four
repetitions were included, when the reflective density
(RD) of each protein band was measured using Quantity
One 4.6.5 software (Biorad).
We found that all strains tested produced FlaB at
approximately the same level (Figure. 4). The reflective
density of the FlaB bands of the wild-type, ΔluxSHp
mutant and the complemented ΔluxSHp
+ mutant were
(means ± SD) 0.210 ± 2.0E-03 RD, n = 4; 0.204 ± 5.8E-
04 RD, n = 4; and 0.207 ± 5.8E-04 RD, n = 4, respec-
tively. We expressed all other results (FlaA and FlgE)
relative to FlaB in each strain. Mutagenesis of LuxSHp
reduced the expression of FlaA relative to FlaB (from
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mutant, p < 0.01), and complementation increased the
ratio back to wild-type levels (mean 1.70 in the
ΔluxSHp
+ mutant, p <0 . 0 1c o m p a r e dw i t ht h eΔluxSHp
mutant). Next, we examined FlgE expression, and a
similar trend was found (wild-type FlgE:FlaB ratio mean
0.74; ΔluxSHp mutant 0.51; complemented ΔluxSHp
+
mutant 0.77; p < 0.01 for differences between ΔluxSHp
mutant and wild-type and complemented stains). These
data show that FlaA and FlgE synthesis was reduced
relative to FlaB in the ΔluxSHp mutant and these
changes were restored by genetic complementation.
AI-2 regulates the transcription of flagellar genes
Previous reports have provided evidence that luxSHp-
dependent QS may occur to modulate motility via tran-
scriptional regulation of flaA or flhA [20]. We utilised
quantitative RT-PCR (qRT-PCR) to screen for altera-
tions in transcription of these and other genes involved
in flagellar assembly to extend our understanding of the
regulatory mechanisms that might be involved. To
exclude an effect of cysteine biosynthesis, exogenous
addition of cysteine was also undertaken. The concen-
tration of cysteine was non-limiting to H. pylori growth.
16 S rRNA transcription was used for normalization and
ureA served as a non-flagella linked gene control
(Figure. 5D).
The flagellar genes tested included several from differ-
ent regulatory hierarchy positions in flagellar synthesis
[33]: class 1 genes flhA (encodes flagellar regulator com-
ponent), motA and motB (encode flagellar motor pro-
teins); class 2 genes flaB (encodes hook-proximal minor
flagellin) and flgE (enodes flagellar hook protein); and
class 3 gene flaA (encodes major flagellin). fliI (encodes
membrane-associated export ATPase of the flagellar
basal body) was also examined (Figure. 5).
For class 1 genes tested, flhA showed a consistent pat-
tern of 1.75 fold reduced transcription (p < 0.001), and
both motA and motB showed a consistent pattern of 2
fold (p < 0.001) reduced transcription in the ΔluxSHp
mutant compared to the wild-type (Figure. 5A).
For class 2 genes tested, flgE was 1.5 fold (p < 0.001)
Figure 3 luxSHp/DPD modulates flagellar morphogenesis. H. pylori cells were co-cultured with AGS cells. Cells were stained with 0.5%
photungstate (PTA). Scale bars represent 2 μm. (A) wild-type, (B) ΔluxSHp, (C) ΔluxSHp
+, (D) wild-type with DPD, (E) ΔluxSHp with DPD and (F)
ΔluxSHp
+ with DPD. DPD was added after 10 h of incubation and once again after 18 h of incubation during co-cultures.
Figure 4 Mutation of luxSHp causes altered flagellin and hook
protein production. Cell lysates of the strains indicated were
subjected to immunoblotting with anti-flagellin (FlaA and FlaB) and
anti-hook protein (FlgE) together [32]. The proteins were measured
in wild-type, ΔluxSHp, ΔluxSHp
+ cultures grown in Brucella broth at
37°C for 24 h. H. pylori strain 17874 wild-type [29] served as the
positive control. Mutants in flaA (a kind gift from Paul O’Toole) and
flgE [30] derived from this strain (17874ΔflaA and 17874ΔflgE) served
as negative controls for identifying FlaA and FlgE, respectively.
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not exhibit any significant change. flaA was the only
class 3 gene tested, which was 3.5 fold (p < 0.001)
down-regulated in the ΔluxSHp mutant compared to the
wild-type (Figure. 5B). Additionally, the transcript of fliI
was also significantly (1.5 fold, p < 0.001) decreased in
the mutant (Figure. 5C).
The reduced transcription of flhA, motA, motB, flgE,
flaA and fliI was restored genetically by the complemen-
tation of the mutant with the wild-type luxSHp gene.
Also, 150 μM DPD was sufficient to restore the tran-
scription of these genes in the ΔluxSHp mutant to levels
similar to the wild-type (Figure. 5E). Although Figure 5E
shows that 50 μM and 150 μM DPD induced almost the
same level of bioluminescence as the wild-type, we
chose to use 150 μM DPD in the complementation
experiment because this concentration was shown to be
more reproducible (it has the smaller error bar). In
wild-type cells, addition of DPD markedly increased
transcription of motA, motB, flaA and flaB,w h i l s tflhA,
flgE and fliI only showed a marginal increase. Exogenous
addition of cysteine to the ΔluxSHp mutant did not
significantly increase transcription of any of the genes
studied; suggesting that addition of cysteine was not
able to restore the transcription of flagellar genes (data
not shown). Consistent with the analysis of protein
levels, these RT-PCR data indicate that luxSHp disrup-
tion has a greater effect upon transcription of flaA than
of flaB. Taken together, these data suggest that the
effect of LuxS in cysteine metabolism does not regulate
expression of flagellar genes, and that the effects on
flagellar gene transcription are likely through AI-2
production.
Discussion
The function of luxSHp is controversial due to putative
roles both in signalling and metabolism. Disruption of
cysteine biosynthesis by independent mutations that had
Figure 5 luxSHp/DPD modulates H. pylori flagellar gene transcription. Transcript levels of (A) flhA, motA, motB; (B) flaB, flgE, flaA; (C) fliI were
determined by qRT-PCR normalised to the levels of the 16 S rRNA gene. (D) Relative expression of ureA was utilised as a non-flagella gene
control. The Y axis shows the relative transcriptional level of each gene in each strain normalised to the level of the same gene in the strain
control (which is J99 wild-type in every case). Values are mean activities of triplicate RNA samples of each strain. Transcript levels were measured
in wild-type and ΔluxSHp cultures grown with or without DPD (150 μM) and in ΔluxSHp
+ cultures grown without DPD. (E) AI-2 activity (using the
previously-described V. harveyi BB170 bioluminescence assay [4]) in DPD solution (at concentrations of 50 μM, 150 μM or 500 μM) and in cell
free culture supernatant (24 h) of H. pylori wild-type, ΔluxSHp and ΔluxSHp
+ strains grown in the Brucella broth (starting OD600 nm of 0.05).
Negative control is Brucella broth alone. A diluted in vitro synthesised AI-2 sample was utilised as a qualitative positive control [8]. Error bars
indicate standard deviation.
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In contrast, the motility defect of a ΔluxSHp mutant of
H. pylori was genetically complemented by luxSHp,o r
chemically complemented by the addition of exogenous
AI-2 but not by exogenous cysteine. The processes
underlying the loss of motility of the ΔluxSHp mutant
were manifested by fewer and shorter flagella that pre-
sumably derived from the altered flagella protein pro-
duction and the modulated expression of a number of
genes linked with flagella assembly and function.
Previous studies have shown that mutations of luxSHp
in H. pylori diminished motility on soft agar. The altered
motility phenotype was restored completely by genetic
complementation with luxSHp or significantly restored by
metabolic complementation with wild-type CFS [18-20].
In contrast to our study, in Osaki et al. and Rader et al.’s
studies complementation of luxSHp was performed by
placing luxSHp at a second site in the chromosome rather
than at the original locus [19,20]. Like these previous
reports, our study shows that abolished motility of J99
ΔluxSHp mutation was restored entirely by complementa-
tion with the luxSHp gene and significantly by in vitro
synthesised AI-2. The previous studies, with complete
complementation of motility with luxSHp through inser-
tion at a new chromosomal locus, argue against polar
effects of luxSHp mutagenesis on other genes which influ-
ence motility. Our study, with complementation with
luxSHp through creating a revertant results in similar
levels of LuxSHp to wild-type and thus better shows that
the phenotypes attributed to the mutant were not due to
secondary mutations elsewhere in the chromosome.
Furthermore, having demonstrated that MccAHp and
MccBHp function consecutively to convert the product
of LuxSHp (homocysteine) into cysteine as part of the
RTSP [15], we reasoned that inactivation of any of these
three enzymes would have a similar influence upon
cysteine biosynthesis, whilst only the ΔluxSHp mutant
would be devoid of AI-2. Thus, if the reduced motility
of the ΔluxSHp mutant derived from disrupted cysteine
biosynthesis, mutants in mccAHp and mccBHp would
have a similar motility defect. Therefore, we performed
an experiment to exclude the possibility that the effect
on motility was due to non-specific secondary metabolic
effects of LuxSHp.T od ot h i s ,w i l d - t y p e ,ΔluxSHp,
ΔmccAHp and ΔmccBHp strains were inoculated on the
same motility plate, allowing the production of AI-2 and
the biosynthesis of cysteine to be isolated from each
other. As expected, only the ΔluxSHp mutant was non-
motile. This, for the first time, suggests that motility of
H. pylori cannot be affected by disrupting the cysteine
provision pathway, but can be blocked by the loss of
luxSHp itself. By using a chemically defined medium, we
confirmed the provision of cysteine had no effect on
motility of H. pylori.
Earlier publications have suggested that AI-2 may not
act as a signal in some bacteria but instead may simply
be a by-product of the important AMC pathway [9]. In
support of this, in some bacteria, production of AI-2
does appear to be associated with metabolic rather than
regulatory phenomena [34]. However, data from our
motility bioassays using both motility plates and micro-
scopy demonstrate that in H. pylori AI-2 (or DPD) con-
trols motility. In our experiments, the shorter flagella
observed in the mutant could result from the observed
alteration in the FlaA:FlaB ratio as previously described
[35,36]. However, proving this would require extensive
immuno-EM analysis with anti-FlaA and anti-FlaB anti-
sera, which is beyond the scope of this work. As flaA
has been confirmed to be essential for motility in
H. pylori while flaB is a structural subunit of the flagel-
lar filament which increases motility [35,36], the change
of the ratio between flagellins FlaA and FlaB may be
one factor resulting in the abolished motility of the
ΔluxSHp mutant. Also, LuxSHp/AI-2 appears to affect
the position of flagella, suggesting that LuxSHp/AI-2
may affect genes involved in the formation of flagella at
the cell poles.
The reduced expression of flagellar motor genes
(motA and motB) which control flagellar rotation may
be a further factor contributing to slower motility of the
ΔluxSHp mutant although it could also be caused by the
lower flagellar number requiring fewer motor units to
encircle each flagellar base. Thus it is likely that the fla-
gella in the ΔluxSHp strain are too short and too few to
form effective flagellar propellers to produce Helicobac-
ter movement. This is in contrast to a previous report
where truncated flagella were only reported in G27
strains that also lacked one of the transcriptional regula-
tors (s
28, flgS or flgM) and where wild-type length fla-
g e l l aw e r er e p o r t e df o rt h eΔluxSHp mutant alone [20].
However, surprisingly in that report, the addition of
DPD to the double mutants lengthened the flagellar
filaments.
Mutants defective in flhA were previously described as
being defective in flagellar apparatus assembly and in
motility. Recently Rust and coworkers (2009) reported
that the anti-sigma factor for s
28, FlgM, interacts with
FlhA at the base of the Helicobacter flagellum and this
interaction modulates the expression of flagellar genes
by s
28 [37]. The decrease in flhA expression, seen in our
ΔluxSHp mutant could explain the change in flagellar
length but not via a FlgM-dependent pathway as seen
by Rader et al. [20], as Rust and coworkers report that
FlgM levels were wild-type in a ΔflhA mutant in Helico-
bacter strains N6 and 88-3887 [37].
Both Rust and co-workers [37] and Neihus and co-
workers [33] show that FlaB is not regulated by the
same regulatory pathway as FlaA, and as FlaB levels in
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we observe in the ΔluxSHp m u t a n ta r el i k e l yt ob ep r e -
dominantly composed of FlaB (normally hook-proximal)
flagellins. These may be extended, to give functional
length propellers by synthesis and assembly of FlaA in
wild-type filaments and in filaments from luxSHp-com-
plemented ΔluxSHp
+ bacteria or ΔluxSHp bacteria+DPD
which have longer flagella.
FlaB and FlgE are both part of the regulon that is con-
trolled by the FlgS/FlgR two component system and the
sigma factor s
54 (RpoN) [33]. Interestingly, though no
significant change in FlaB was found, FlgE production as
well as its gene expression was affected by loss of LuxS/
AI-2. This suggests that luxS inactivation might affect
transcription of the same class of flagellar genes differ-
ently. One possibility is that the FlgR/FlgS-s
54 regula-
tory complex might have different effects on the same
class of genes when affected by loss of LuxS; another
possibility is that there may be additional regulation
from the other regulator genes, for example flhF.
Flagellar assembly uses a secretion apparatus similar
to type III secretion systems. This is dependent upon
export chaperones that protect and transport structural
subunits using the membrane-associated export ATPase,
FliI [38,39]. Therefore, the decreased transcription of fliI
might be another factor in blocking motility via shor-
tened filament length in the ΔluxSHp mutant as Helico-
bacter fliI mutants are non-motile and synthesise
reduced amounts of flagellin (FlaA, FlaB) and hook pro-
tein (FlgE) subunits [38].
In our experiments, the motility defect, down-regu-
lated flagellar gene expression and reduced synthesis of
flagellar proteins in the ΔluxSHp mutant were due to
loss of AI-2 only, and not to the metabolic effect of
luxSHp on biosynthesis of cysteine. These results suggest
that LuxS/AI-2 is likely to be a functional signalling sys-
tem contributing to control motility in H. pylori.H o w -
ever, it is still uncertain whether AI-2 functions as a
true QS signal in H. pylori, in part because there are no
genes encoding proteins that can be confidently identi-
fied as components of an AI-2 sensory and regulatory
apparatus in H. pylori [13,40]. Also, we cannot exclude
the possibility that AI-2 acts through other undefined
effects and not as a signalling molecule, although as it is
known to have similar effects through signalling in
other bacteria, this appears unlikely.
Campylobacter jejuni also possesses a luxS homologue
and produces AI-2. Inactivation of luxS in a C. jejuni
strain (81-176) also resulted in reduced motility and
affected transcription of some genes [41]. However,
despite its effect on signalling, AI-2 does not function as
a QS molecule in C. jejuni (NCTC 11168) during expo-
nential growth in vitro when a high level of AI-2 is pro-
duced [42]. Thus, so far there is no good evidence to
ascertain whether AI-2 functions as a true QS signal in
this species. In H. pylori,L e eet al. and Osaki et al.
looked at fitness of ΔluxSHp mutants in vivo using mouse
and gerbil models, respectively [18,19]. The authors did
not favour a QS or even a signalling explanation for the
reduced fitness mechanisms but both speculated that it
might be caused by metabolic disturbances upon loss of
luxSHp [18,19]. However, it could potentially be explained
by reduced signalling leading to reduced motility, and
given the ecological niche of H. pylori there would be
logic to a signalling (perhaps even QS) system increasing
motility. For example, we speculate that if a microcolony
of H. pylori in a particular area of the stomach reached a
critical size it would be potentially advantageous for fla-
gellar biogenesis to be enhanced so that highly motile
bacteria could disseminate to new regions of the sto-
mach. If this hypothesis was confirmed, it would have
important implications for H. pylori virulence and for the
spread of infection within and between people.
Conclusions
Our study suggests that as well as being a metabolic
enzyme in the reverse transsulphuration pathway,
H. pylori LuxS has a second role in regulation of moti-
lity by modulating flagellar transcripts and flagellar bio-
synthesis. This is achieved through production of the
signalling molecule AI-2, rather than the metabolic
effect of LuxS in cysteine biosynthesis.
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